Mylan Of U.S. Seeks To Buy 15 Percent Of India’s Famy Care
This article was originally published in PharmAsia News
Executive Summary
U.S. generics maker Mylan is negotiating with Famy Care of India to buy a 15 percent share in India's leading maker of contraceptives. The deal would be Mylan's second in India--it bought a 51 percent stake earlier in Matrix Labs. Mylan and Famy already have a marketing pact to sell Famy products in the United States. Famy's managing director, Sanjeev Taparia, would not confirm the Mylan deal, but acknowledged his company was looking to sell some equity. (Click here for more